To select the best therapy and estimate prognosis, invasive breast cancers are categorized into different molecular subtypes, including luminal A, luminal B (HER2-), luminal B (HER2+), Her2 positive and triple negative breast cancers (TNBC) (Schnitt 2010). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.